Compare CLDX & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | FBP |
|---|---|---|
| Founded | N/A | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.7B |
| IPO Year | 1995 | 2010 |
| Metric | CLDX | FBP |
|---|---|---|
| Price | $30.73 | $24.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $46.60 | $25.50 |
| AVG Volume (30 Days) | 631.7K | ★ 976.1K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 18.78 |
| EPS | N/A | ★ 0.57 |
| Revenue | $12,743,000.00 | ★ $1,255,034,000.00 |
| Revenue This Year | $111.39 | $15.10 |
| Revenue Next Year | $235.85 | $4.65 |
| P/E Ratio | ★ N/A | $42.37 |
| Revenue Growth | ★ 87.78 | 2.38 |
| 52 Week Low | $18.56 | $19.16 |
| 52 Week High | $35.83 | $24.57 |
| Indicator | CLDX | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 58.70 |
| Support Level | $28.30 | $23.05 |
| Resistance Level | $30.90 | $24.54 |
| Average True Range (ATR) | 1.45 | 0.45 |
| MACD | -0.33 | -0.03 |
| Stochastic Oscillator | 26.46 | 74.10 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.